Changkun Li, Yixuan Sunhe, Hui Zhou, & Weihua Dong. (2023). Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis. Taylor & Francis Group.
Chicago Style (17th ed.) CitationChangkun Li, Yixuan Sunhe, Hui Zhou, and Weihua Dong. Efficacy and Safety Evaluations of Adalimumab Biosimilars in the Treatment of Psoriasis. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationChangkun Li, et al. Efficacy and Safety Evaluations of Adalimumab Biosimilars in the Treatment of Psoriasis. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.